Pioglitazone-induced hepatic injury in a patient previously receiving troglitazone with success

被引：24

作者：

Nagasaka, S ^{[1
]}

Abe, T ^{[1
]}

Kawakami, A ^{[1
]}

Kusaka, I ^{[1
]}

Nakamura, T ^{[1
]}

Ishikawa, S ^{[1
]}

Saito, T ^{[1
]}

Ishibashi, S ^{[1
]}

机构：

[1] Jichi Med Sch, Dept Med, Div Endocrinol & Metab, Minami Kawachi, Tochigi, Japan

来源：

DIABETIC MEDICINE | 2002年 / 19卷 / 04期

关键词：

D O I：

10.1046/j.1464-5491.2002.00712_4.x

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

引用

收藏

页码：347 / 348

页数：2

相关论文

共 6 条

[1] Al-Salman J, 2000, ANN INTERN MED, V132, P121, DOI 10.7326/0003-4819-132-2-200001180-00006
[2] Hepatic failure in a patient taking rosiglitazone
Forman, LM
Simmons, DA
Diamond, RH
[J]. ANNALS OF INTERNAL MEDICINE, 2000, 132 (02) : 118 - 121
[3] Failure to develop hepatic injury from rosiglitazone in a patient with a history of troglitazone-induced hepatitis
Lenhard, MJ
Funk, WB
[J]. DIABETES CARE, 2001, 24 (01) : 168 - 169
[4] HOMEOSTASIS MODEL ASSESSMENT - INSULIN RESISTANCE AND BETA-CELL FUNCTION FROM FASTING PLASMA-GLUCOSE AND INSULIN CONCENTRATIONS IN MAN
MATTHEWS, DR
HOSKER, JP
RUDENSKI, AS
NAYLOR, BA
TREACHER, DF
TURNER, RC
[J]. DIABETOLOGIA, 1985, 28 (07) : 412 - 419
[5] Efficacy of troglitazone measured by insulin resistance index
Nagasaka, S
Iwamoto, Y
Ishikawa, S
Kuzuya, T
Saito, T
[J]. LANCET, 1997, 350 (9072) : 184 - 184
[6] Thiazolidinediones in the treatment of insulin resistance and type II diabetes
Saltiel, AR
Olefsky, JM
[J]. DIABETES, 1996, 45 (12) : 1661 - 1669